Global Genomics In Cancer Care Market Research Report 2023

Report ID: 1991157 | Published Date: Sep 2024 | No. of Page: 101 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Instruments
        1.2.3 Consumables
        1.2.4 Services
    1.3 Market by Application
        1.3.1 Global Genomics In Cancer Care Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Diagnostics
        1.3.3 Personalized Medicine
        1.3.4 Drug Discovery
        1.3.5 Development
        1.3.6 Research
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Genomics In Cancer Care Market Perspective (2017-2028)
    2.2 Genomics In Cancer Care Growth Trends by Region
        2.2.1 Genomics In Cancer Care Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Genomics In Cancer Care Historic Market Size by Region (2017-2022)
        2.2.3 Genomics In Cancer Care Forecasted Market Size by Region (2023-2028)
    2.3 Genomics In Cancer Care Market Dynamics
        2.3.1 Genomics In Cancer Care Industry Trends
        2.3.2 Genomics In Cancer Care Market Drivers
        2.3.3 Genomics In Cancer Care Market Challenges
        2.3.4 Genomics In Cancer Care Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Genomics In Cancer Care Players by Revenue
        3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2017-2022)
        3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2017-2022)
    3.2 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
    3.4 Global Genomics In Cancer Care Market Concentration Ratio
        3.4.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2021
    3.5 Genomics In Cancer Care Key Players Head office and Area Served
    3.6 Key Players Genomics In Cancer Care Product Solution and Service
    3.7 Date of Enter into Genomics In Cancer Care Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics In Cancer Care Breakdown Data by Type
    4.1 Global Genomics In Cancer Care Historic Market Size by Type (2017-2022)
    4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2023-2028)
5 Genomics In Cancer Care Breakdown Data by Application
    5.1 Global Genomics In Cancer Care Historic Market Size by Application (2017-2022)
    5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Genomics In Cancer Care Market Size (2017-2028)
    6.2 North America Genomics In Cancer Care Market Size by Country (2017-2022)
    6.3 North America Genomics In Cancer Care Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Genomics In Cancer Care Market Size (2017-2028)
    7.2 Europe Genomics In Cancer Care Market Size by Country (2017-2022)
    7.3 Europe Genomics In Cancer Care Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Genomics In Cancer Care Market Size (2017-2028)
    8.2 Asia-Pacific Genomics In Cancer Care Market Size by Country (2017-2022)
    8.3 Asia-Pacific Genomics In Cancer Care Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Genomics In Cancer Care Market Size (2017-2028)
    9.2 Latin America Genomics In Cancer Care Market Size by Country (2017-2022)
    9.3 Latin America Genomics In Cancer Care Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Genomics In Cancer Care Market Size (2017-2028)
    10.2 Middle East & Africa Genomics In Cancer Care Market Size by Country (2017-2022)
    10.3 Middle East & Africa Genomics In Cancer Care Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Illumina
        11.1.1 Illumina Company Detail
        11.1.2 Illumina Business Overview
        11.1.3 Illumina Genomics In Cancer Care Introduction
        11.1.4 Illumina Revenue in Genomics In Cancer Care Business (2017-2022)
        11.1.5 Illumina Recent Development
    11.2 Thermo Fisher scientific
        11.2.1 Thermo Fisher scientific Company Detail
        11.2.2 Thermo Fisher scientific Business Overview
        11.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
        11.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2017-2022)
        11.2.5 Thermo Fisher scientific Recent Development
    11.3 Agilent
        11.3.1 Agilent Company Detail
        11.3.2 Agilent Business Overview
        11.3.3 Agilent Genomics In Cancer Care Introduction
        11.3.4 Agilent Revenue in Genomics In Cancer Care Business (2017-2022)
        11.3.5 Agilent Recent Development
    11.4 Roche
        11.4.1 Roche Company Detail
        11.4.2 Roche Business Overview
        11.4.3 Roche Genomics In Cancer Care Introduction
        11.4.4 Roche Revenue in Genomics In Cancer Care Business (2017-2022)
        11.4.5 Roche Recent Development
    11.5 Cancer Genetics
        11.5.1 Cancer Genetics Company Detail
        11.5.2 Cancer Genetics Business Overview
        11.5.3 Cancer Genetics Genomics In Cancer Care Introduction
        11.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2017-2022)
        11.5.5 Cancer Genetics Recent Development
    11.6 Beckman Coulter
        11.6.1 Beckman Coulter Company Detail
        11.6.2 Beckman Coulter Business Overview
        11.6.3 Beckman Coulter Genomics In Cancer Care Introduction
        11.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2017-2022)
        11.6.5 Beckman Coulter Recent Development
    11.7 Bio-Rad
        11.7.1 Bio-Rad Company Detail
        11.7.2 Bio-Rad Business Overview
        11.7.3 Bio-Rad Genomics In Cancer Care Introduction
        11.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2017-2022)
        11.7.5 Bio-Rad Recent Development
    11.8 Danaher
        11.8.1 Danaher Company Detail
        11.8.2 Danaher Business Overview
        11.8.3 Danaher Genomics In Cancer Care Introduction
        11.8.4 Danaher Revenue in Genomics In Cancer Care Business (2017-2022)
        11.8.5 Danaher Recent Development
    11.9 Sigma Aldrich
        11.9.1 Sigma Aldrich Company Detail
        11.9.2 Sigma Aldrich Business Overview
        11.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
        11.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2017-2022)
        11.9.5 Sigma Aldrich Recent Development
    11.10 Pacific Biosciences
        11.10.1 Pacific Biosciences Company Detail
        11.10.2 Pacific Biosciences Business Overview
        11.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
        11.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2017-2022)
        11.10.5 Pacific Biosciences Recent Development
    11.11 Quest Diagnostics
        11.11.1 Quest Diagnostics Company Detail
        11.11.2 Quest Diagnostics Business Overview
        11.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
        11.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2017-2022)
        11.11.5 Quest Diagnostics Recent Development
    11.12 Luminex
        11.12.1 Luminex Company Detail
        11.12.2 Luminex Business Overview
        11.12.3 Luminex Genomics In Cancer Care Introduction
        11.12.4 Luminex Revenue in Genomics In Cancer Care Business (2017-2022)
        11.12.5 Luminex Recent Development
    11.13 Oxford Gene Technology
        11.13.1 Oxford Gene Technology Company Detail
        11.13.2 Oxford Gene Technology Business Overview
        11.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
        11.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2017-2022)
        11.13.5 Oxford Gene Technology Recent Development
    11.14 PerkinElmer
        11.14.1 PerkinElmer Company Detail
        11.14.2 PerkinElmer Business Overview
        11.14.3 PerkinElmer Genomics In Cancer Care Introduction
        11.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2017-2022)
        11.14.5 PerkinElmer Recent Development
    11.15 Qiagen
        11.15.1 Qiagen Company Detail
        11.15.2 Qiagen Business Overview
        11.15.3 Qiagen Genomics In Cancer Care Introduction
        11.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2017-2022)
        11.15.5 Qiagen Recent Development
    11.16 GE Healthcare
        11.16.1 GE Healthcare Company Detail
        11.16.2 GE Healthcare Business Overview
        11.16.3 GE Healthcare Genomics In Cancer Care Introduction
        11.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2017-2022)
        11.16.5 GE Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Instruments
    Table 3. Key Players of Consumables
    Table 4. Key Players of Services
    Table 5. Global Genomics In Cancer Care Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Genomics In Cancer Care Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Genomics In Cancer Care Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Genomics In Cancer Care Market Share by Region (2017-2022)
    Table 9. Global Genomics In Cancer Care Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Genomics In Cancer Care Market Share by Region (2023-2028)
    Table 11. Genomics In Cancer Care Market Trends
    Table 12. Genomics In Cancer Care Market Drivers
    Table 13. Genomics In Cancer Care Market Challenges
    Table 14. Genomics In Cancer Care Market Restraints
    Table 15. Global Genomics In Cancer Care Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Genomics In Cancer Care Market Share by Players (2017-2022)
    Table 17. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2021)
    Table 18. Ranking of Global Top Genomics In Cancer Care Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Genomics In Cancer Care Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Genomics In Cancer Care Product Solution and Service
    Table 22. Date of Enter into Genomics In Cancer Care Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Genomics In Cancer Care Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Genomics In Cancer Care Revenue Market Share by Type (2017-2022)
    Table 26. Global Genomics In Cancer Care Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Genomics In Cancer Care Revenue Market Share by Type (2023-2028)
    Table 28. Global Genomics In Cancer Care Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Genomics In Cancer Care Revenue Market Share by Application (2017-2022)
    Table 30. Global Genomics In Cancer Care Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Genomics In Cancer Care Revenue Market Share by Application (2023-2028)
    Table 32. North America Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Genomics In Cancer Care Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Genomics In Cancer Care Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Illumina Company Detail
    Table 43. Illumina Business Overview
    Table 44. Illumina Genomics In Cancer Care Product
    Table 45. Illumina Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 46. Illumina Recent Development
    Table 47. Thermo Fisher scientific Company Detail
    Table 48. Thermo Fisher scientific Business Overview
    Table 49. Thermo Fisher scientific Genomics In Cancer Care Product
    Table 50. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 51. Thermo Fisher scientific Recent Development
    Table 52. Agilent Company Detail
    Table 53. Agilent Business Overview
    Table 54. Agilent Genomics In Cancer Care Product
    Table 55. Agilent Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 56. Agilent Recent Development
    Table 57. Roche Company Detail
    Table 58. Roche Business Overview
    Table 59. Roche Genomics In Cancer Care Product
    Table 60. Roche Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 61. Roche Recent Development
    Table 62. Cancer Genetics Company Detail
    Table 63. Cancer Genetics Business Overview
    Table 64. Cancer Genetics Genomics In Cancer Care Product
    Table 65. Cancer Genetics Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 66. Cancer Genetics Recent Development
    Table 67. Beckman Coulter Company Detail
    Table 68. Beckman Coulter Business Overview
    Table 69. Beckman Coulter Genomics In Cancer Care Product
    Table 70. Beckman Coulter Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 71. Beckman Coulter Recent Development
    Table 72. Bio-Rad Company Detail
    Table 73. Bio-Rad Business Overview
    Table 74. Bio-Rad Genomics In Cancer Care Product
    Table 75. Bio-Rad Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 76. Bio-Rad Recent Development
    Table 77. Danaher Company Detail
    Table 78. Danaher Business Overview
    Table 79. Danaher Genomics In Cancer Care Product
    Table 80. Danaher Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 81. Danaher Recent Development
    Table 82. Sigma Aldrich Company Detail
    Table 83. Sigma Aldrich Business Overview
    Table 84. Sigma Aldrich Genomics In Cancer Care Product
    Table 85. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 86. Sigma Aldrich Recent Development
    Table 87. Pacific Biosciences Company Detail
    Table 88. Pacific Biosciences Business Overview
    Table 89. Pacific Biosciences Genomics In Cancer Care Product
    Table 90. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 91. Pacific Biosciences Recent Development
    Table 92. Quest Diagnostics Company Detail
    Table 93. Quest Diagnostics Business Overview
    Table 94. Quest Diagnostics Genomics In Cancer CareProduct
    Table 95. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 96. Quest Diagnostics Recent Development
    Table 97. Luminex Company Detail
    Table 98. Luminex Business Overview
    Table 99. Luminex Genomics In Cancer CareProduct
    Table 100. Luminex Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 101. Luminex Recent Development
    Table 102. Oxford Gene Technology Company Detail
    Table 103. Oxford Gene Technology Business Overview
    Table 104. Oxford Gene Technology Genomics In Cancer CareProduct
    Table 105. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 106. Oxford Gene Technology Recent Development
    Table 107. PerkinElmer Company Detail
    Table 108. PerkinElmer Business Overview
    Table 109. PerkinElmer Genomics In Cancer CareProduct
    Table 110. PerkinElmer Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 111. PerkinElmer Recent Development
    Table 112. Qiagen Company Detail
    Table 113. Qiagen Business Overview
    Table 114. Qiagen Genomics In Cancer CareProduct
    Table 115. Qiagen Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 116. Qiagen Recent Development
    Table 117. GE Healthcare Company Detail
    Table 118. GE Healthcare Business Overview
    Table 119. GE Healthcare Genomics In Cancer CareProduct
    Table 120. GE Healthcare Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 121. GE Healthcare Recent Development
    Table 122. Research Programs/Design for This Report
    Table 123. Key Data Information from Secondary Sources
    Table 124. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Genomics In Cancer Care Market Share by Type: 2021 VS 2028
    Figure 2. Instruments Features
    Figure 3. Consumables Features
    Figure 4. Services Features
    Figure 5. Global Genomics In Cancer Care Market Share by Application in 2021 & 2028
    Figure 6. Diagnostics Case Studies
    Figure 7. Personalized Medicine Case Studies
    Figure 8. Drug Discovery Case Studies
    Figure 9. Development Case Studies
    Figure 10. Research Case Studies
    Figure 11. Genomics In Cancer Care Report Years Considered
    Figure 12. Global Genomics In Cancer Care Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Genomics In Cancer Care Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Genomics In Cancer Care Market Share by Region: 2021 VS 2028
    Figure 15. Global Genomics In Cancer Care Market Share by Players in 2021
    Figure 16. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2021
    Figure 18. North America Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Genomics In Cancer Care Market Share by Country (2017-2028)
    Figure 20. United States Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Genomics In Cancer Care Market Share by Country (2017-2028)
    Figure 24. Germany Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Genomics In Cancer Care Market Share by Region (2017-2028)
    Figure 32. China Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Genomics In Cancer Care Market Share by Country (2017-2028)
    Figure 40. Mexico Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Genomics In Cancer Care Market Share by Country (2017-2028)
    Figure 44. Turkey Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 47. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 48. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 49. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 50. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 51. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 52. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 53. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 54. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 55. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 56. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 57. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 58. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 59. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 60. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 61. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Illumina
Thermo Fisher scientific
Agilent
Roche
Cancer Genetics
Beckman Coulter
Bio-Rad
Danaher
Sigma Aldrich
Pacific Biosciences
Quest Diagnostics
Luminex
Oxford Gene Technology
PerkinElmer
Qiagen
GE Healthcare
Frequently Asked Questions
Genomics In Cancer Care report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Genomics In Cancer Care report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Genomics In Cancer Care report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Geriatric Medicine

Geriatric Medicine market is segmented by players, region (country), by Type and by Application.  ... Read More

Gonorrhea Diagnostic

Gonorrhea Diagnostic market is segmented by players, region (country), by Type and by Application ... Read More